CEPSA has begun constructing a plant to produce 80,000 mt of isopropyl alcohol in Spain. The new facility represents an investment of € 75 million. The facility will be...

Aurigene Pharmaceutical Services Limited (Aurigene), a Dr. Reddy’s Laboratories Limited company, inaugurated its biologics facility spread across 6500 m2 (70,000 sq ft)...

Bionova Scientific, part of Asahi Kasei and full-service biologics contract development and manufacturing organization (CDMO), plans to expand into plasmid DNA (pDNA)...

UK-headquartered contract development and manufacturing organization (CDMO) Sterling Pharma Solutions has invested $3 million at its US facility in Germantown, WI, to...

Enzene Biosciences, a global CDMO announces the launch of a new Drug Discovery Division.

South Korean conglomerate Hanwha and Ineos Nitriles intend to collaborate in a study for a low-carbon ammonia facility with carbon sequestration in the US, with a...

Asahi Kasei Medical has completed the construction of its third assembly plant for Planova virus removal filters in Nobeoka, Miyazaki, Japan.

Eli Lilly plans to invest another $5.3 billion in its US manufacturing site Lebanon, Indiana, increasing the company's total investment in this site $9 billion. The...